STE20-type kinase TAOK3 regulates hepatic lipid partitioning

Molecular Metabolism - Tập 54 - Trang 101353 - 2021
Ying Xia1, Mara Caputo1, Emmelie Cansby1, Sumit Kumar Anand1, Silva Sütt1, Marcus Henricsson2,3, Rando Porosk4, Hanns-Ulrich Marschall3, Matthias Blüher5, Margit Mahlapuu1
1Department of Chemistry and Molecular Biology, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
2Biomarker Discovery and Development, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
3Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
4Department of Biochemistry, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
5Department of Medicine, University of Leipzig, Leipzig, Germany

Tài liệu tham khảo

Powell, 2021, Non-alcoholic fatty liver disease, Lancet, 10.1016/S0140-6736(20)32511-3 Geier, 2021, From the origin of NASH to the future of metabolic fatty liver disease, Gut, 10.1136/gutjnl-2020-323202 Sheka, 2020, Nonalcoholic steatohepatitis: a review, Journal of the American Medical Association, 323, 1175, 10.1001/jama.2020.2298 Anstee, 2019, From NASH to HCC: current concepts and future challenges, Nature Reviews Gastroenterology & Hepatology, 16, 411, 10.1038/s41575-019-0145-7 Gluchowski, 2017, Lipid droplets and liver disease: from basic biology to clinical implications, Nature Reviews Gastroenterology & Hepatology, 14, 343, 10.1038/nrgastro.2017.32 Mashek, 2015, Hepatic lipid droplet biology: getting to the root of fatty liver, Hepatology, 62, 964, 10.1002/hep.27839 Abul-Husn, 2018, A protein-truncating HSD17B13 variant and protection from chronic liver disease, New England Journal of Medicine, 378, 1096, 10.1056/NEJMoa1712191 Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nature Genetics, 40, 1461, 10.1038/ng.257 Amrutkar, 2015, Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH, The FASEB Journal, 29, 1564, 10.1096/fj.14-264937 Amrutkar, 2016, STK25 is a critical determinant in nonalcoholic steatohepatitis, The FASEB Journal, 30, 3628, 10.1096/fj.201600562R Amrutkar, 2016, Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans, Diabetologia, 59, 341, 10.1007/s00125-015-3801-7 Cansby, 2019, Targeted delivery of Stk25 antisense oligonucleotides to hepatocytes protects mice against nonalcoholic fatty liver disease, Cell and Molecular Gastroenterology and Hepatology, 7, 597, 10.1016/j.jcmgh.2018.12.004 Nunez-Duran, 2018, Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice, International Hepatology Communications, 2, 69, 10.1002/hep4.1128 Nerstedt, 2020, Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver, The Journal of Lipid Research, 61, 178, 10.1194/jlr.RA119000316 Cansby, 2019, Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans, The FASEB Journal, 33, 9974, 10.1096/fj.201900356RR Caputo, 2021, Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease, The FASEB Journal, 35, 10.1096/fj.202002671RR Caputo, 2021, STE20-Type protein kinase MST4 controls NAFLD progression by regulating lipid droplet dynamics and metabolic stress in hepatocytes, International Hepatology Communications, 5, 1183, 10.1002/hep4.1702 Bian, 2019, Target deconvolution of a multikinase inhibitor with antimetastatic properties identifies TAOK3 as a key contributor to a cancer stem cell-like phenotype, Molecular Cancer Therapeutics, 18, 2097, 10.1158/1535-7163.MCT-18-1011 Kapfhamer, 2012, JNK pathway activation is controlled by tao/TAOK3 to modulate ethanol sensitivity, PLoS One, 7, 10.1371/journal.pone.0050594 Hammad, 2017, Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10, Nature Immunology, 18, 313, 10.1038/ni.3657 Vanderkerken, 2020, TAO-kinase 3 governs the terminal differentiation of conventional dendritic cells, Proceedings of the National Academy of Sciences of the United States of America, 117, 31331, 10.1073/pnas.2009847117 Ormonde, 2018, TAOK3 regulates canonical TCR signaling by preventing early SHP-1-Mediated inactivation of LCK, The Journal of Immunology, 201, 3431, 10.4049/jimmunol.1800284 Lai, 2020, Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-kappa B signaling pathway, Cell Communication and Signaling, 18, 10.1186/s12964-020-00600-2 Kannt, 2015, Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance, Diabetologia, 58, 799, 10.1007/s00125-014-3490-7 Brunt, 1999, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, American Journal of Gastroenterology, 94, 2467, 10.1111/j.1572-0241.1999.01377.x Samanez, 2012, The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism, Archives of Physiology and Biochemistry, 118, 102, 10.3109/13813455.2012.683442 Lofgren, 2012, The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma, Journal of Lipid Research, 53, 1690, 10.1194/jlr.D023036 Homan, 1998, Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection, Journal of Chromatography B, 708, 21, 10.1016/S0378-4347(97)00651-8 Stahlman, 2013, Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1831, 1609, 10.1016/j.bbalip.2013.07.009 Porosk, 2017, Metabolomics of the wolfram syndrome 1 gene (Wfs1) deficient mice, Omics, 21, 721, 10.1089/omi.2017.0143 Cansby, 2013, Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet, The FASEB Journal, 27, 3660, 10.1096/fj.13-228494 Vojtek, 1995, Ras-Raf interaction: two-hybrid analysis, Methods in Enzymology, 255, 331, 10.1016/S0076-6879(95)55036-4 Bartel, 1993, Using the two-hybrid system to detect protein–protein interactions, 153 Fromont-Racine, 1997, Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens, Nature Genetics, 16, 277, 10.1038/ng0797-277 Bonneaud, 1991, A family of low and high copy replicative, integrative and single-stranded S. cerevisiae/E. coli shuttle vectors, Yeast, 7, 609, 10.1002/yea.320070609 Mumberg, 1994, Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression, Nucleic Acids Research, 22, 5767, 10.1093/nar/22.25.5767 Formstecher, 2005, Protein interaction mapping: a Drosophila case study, Genome Research, 15, 376, 10.1101/gr.2659105 Wojcik, 2002, Prediction, assessment and validation of protein interaction maps in bacteria, Journal of Molecular Biology, 323, 763, 10.1016/S0022-2836(02)01009-4 Rain, 2001, The protein-protein interaction map of Helicobacter pylori, Nature, 409, 211, 10.1038/35051615 Dyson, 2014, Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team, Journal of Hepatology, 60, 110, 10.1016/j.jhep.2013.08.011 Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nature Reviews Gastroenterology & Hepatology, 10, 330, 10.1038/nrgastro.2013.41 Sanyal, 2010, Population-based risk factors and resource utilization for HCC: US perspective, Current Medical Research and Opinion, 26, 2183, 10.1185/03007995.2010.506375 Su, 2014, Comparative proteomic study reveals 17beta-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease, Proceedings of the National Academy of Sciences of the United States of America, 111, 11437, 10.1073/pnas.1410741111 Krahmer, 2013, Protein correlation profiles identify lipid droplet proteins with high confidence, Molecular & Cellular Proteomics, 12, 1115, 10.1074/mcp.M112.020230 Fang, 2020, The diverse roles of TAO kinases in health and diseases, International Journal of Molecular Sciences, 21, 10.3390/ijms21207463 Mashek, 2020, Hepatic lipid droplets: a balancing act between energy storage and metabolic dysfunction in NAFLD, Molecular Metabolism, 50 Yang, 2010, The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase, Cell Metabolism, 11, 194, 10.1016/j.cmet.2010.02.003 Martinez-Lopez, 2015, Autophagy and lipid droplets in the liver, Annual Review of Nutrition, 35, 215, 10.1146/annurev-nutr-071813-105336 Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nature Medicine, 24, 908, 10.1038/s41591-018-0104-9 Li, 2020, TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization, Biochemistry and Biophysics Research Corporation, 531, 497, 10.1016/j.bbrc.2020.07.060 MacKeigan, 2005, Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance, Nature Cell Biology, 7, 591, 10.1038/ncb1258 Yustein, 2003, Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38, Oncogene, 22, 6129, 10.1038/sj.onc.1206605 Preisinger, 2004, YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3zeta, The Journal of Cell Biology, 164, 1009, 10.1083/jcb.200310061 Matsuki, 2010, Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment, Cell, 143, 826, 10.1016/j.cell.2010.10.029 Voss, 2007, CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations, Neurogenetics, 8, 249, 10.1007/s10048-007-0098-9 Fidalgo, 2010, CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation, Journal of Cell Science, 123, 1274, 10.1242/jcs.061341 Filippi, 2011, MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases, The EMBO Journal, 30, 1730, 10.1038/emboj.2011.78 Sanyal, 2019, Past, present and future perspectives in nonalcoholic fatty liver disease, Nature Reviews Gastroenterology & Hepatology, 16, 377, 10.1038/s41575-019-0144-8 Win, 2016, c-Jun N-terminal kinase mediates mouse liver injury through a novel sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial src, Hepatology, 63, 1987, 10.1002/hep.28486 Leboucher, 2012, Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis, Molecular Cell, 47, 547, 10.1016/j.molcel.2012.05.041